组织细胞外囊泡多组学揭示动脉粥样硬化与钙化性主动脉瓣狭窄的独特调控因子
研究对颈动脉斑块和钙化主动脉瓣组织进行疾病阶段特异性蛋白质组学及组织来源细胞外囊泡的多组学分析,发现两种疾病蛋白质组既有显著汇聚又各自保留独特差异蛋白,囊泡货物在两种组织中分别关联Notch和Wnt信号,敲低组织特异性囊泡分子可显著调控钙化。
要点
- 组织来源细胞外囊泡多组学可区分动脉粥样硬化与钙化性主动脉瓣狭窄的独特驱动因子。
- 颈动脉斑块与钙化瓣膜蛋白质组存在显著汇聚,但各自保留独特差异富集蛋白。
- 敲低组织特异性囊泡分子FGFR2、PPP2CA、ADAM17及WNT5A、APP、APC可显著调控钙化。
核心结论
- 首次对人颈动脉斑块与钙化主动脉瓣进行比较蛋白质组学研究,识别动脉粥样硬化与主动脉瓣狭窄的独特驱动因子,并提示细胞外囊泡参与晚期心血管钙化。
研究设计与样本
- 对颈动脉内膜切除标本(n=16)和狭窄主动脉瓣(n=18)进行疾病阶段特异性蛋白质组学分析。
- 通过酶消化、超速离心和15级密度梯度从人颈动脉(正常n=6,病变n=4)和主动脉瓣(正常n=6,病变n=4)中分离组织细胞外囊泡,并用蛋白质组学、CD63免疫金电镜和纳米颗粒跟踪分析验证。
- 对组织细胞外囊泡进行囊泡蛋白质组学和小RNA测序,用TargetScan识别microRNA靶点,并通过通路网络分析优先选择基因在人原代颈动脉平滑肌细胞和主动脉瓣间质细胞中验证。
主要发现
- 疾病进展驱动颈动脉斑块和钙化主动脉瓣蛋白质组显著汇聚(P<0.0001,2318种蛋白质)。
- 每种组织保留独特差异富集蛋白子集(斑块381种,瓣膜226种,q<0.05)。
- 在两种组织中受疾病调控的蛋白质里,囊泡基因本体术语增加2.9倍(P<0.0001)。
- 蛋白质组学在组织消化组分中识别22种细胞外囊泡标志物。
- 囊泡组学识别773种蛋白质和80种microRNA仅因疾病在动脉或瓣膜囊泡中差异富集(q<0.05),多组学整合发现组织特异性囊泡货物分别与颈动脉促钙化Notch信号和主动脉瓣Wnt信号相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fewer than 50% of patients who develop aortic valve calcification have concomitant atherosclerosis, implying differential pathogenesis. Although circulating extracellular vesicles (EVs) act as biomarkers of cardiovascular diseases, tissue-entrapped EVs are associated with early mineralization, but their cargoes, functions, and contributions to disease remain unknown. METHODS: Disease stage-specific proteomics was performed on human carotid endarterectomy specimens (n=16) and stenotic aortic valves (n=18). Tissue EVs were isolated from human carotid arteries (normal, n=6; diseased, n=4) and aortic valves (normal, n=6; diseased, n=4) by enzymatic digestion, (ultra)centrifugation, and a 15-fraction density gradient validated by proteomics, CD63-immunogold electron microscopy, and nanoparticle tracking analysis. Vesiculomics, comprising vesicular proteomics and small RNA-sequencing, was conducted on tissue EVs. TargetScan identified microRNA targets. Pathway network analyses prioritized genes for validation in primary human carotid artery smooth muscle cells and aortic valvular interstitial cells. RESULTS: Disease progression drove significant convergence (P<0.0001) of carotid artery plaque and calcified aortic valve proteomes (2318 proteins). Each tissue also retained a unique subset of differentially enriched proteins (381 in plaques; 226 in valves; q<0.05). Vesicular gene ontology terms increased 2.9-fold (P<0.0001) among proteins modulated by disease in both tissues. Proteomics identified 22 EV markers in tissue digest fractions. Networks of proteins and microRNA targets changed by disease progression in both artery and valve EVs revealed shared involvement in intracellular signaling and cell cycle regulation. Vesiculomics identified 773 proteins and 80 microRNAs differentially enriched by disease exclusively in artery or valve EVs (q<0.05); multiomics integration found tissue-specific EV cargoes associated with procalcific Notch and Wnt signaling in carotid arteries and aortic valves, respectively. Knockdown of tissue-specific EV-derived molecules FGFR2, PPP2CA, and ADAM17 in human carotid artery smooth muscle cells and WNT5A, APP, and APC in human aortic valvular interstitial cells significantly modulated calcification. CONCLUSIONS: The first comparative proteomics study of human carotid artery plaques and calcified aortic valves identifies unique drivers of atherosclerosis versus aortic valve stenosis and implicates EVs in advanced cardiovascular calcification. We delineate a vesiculomics strategy to isolate, purify, and study protein and RNA cargoes from EVs entrapped in fibrocalcific tissues. Integration of vesicular proteomics and transcriptomics by network approaches revealed novel roles for tissue EVs in modulating cardiovascular disease.
引用
- Blaser MC, Buffolo F, Halu A, et al. Multiomics of Tissue Extracellular Vesicles Identifies Unique Modulators of Atherosclerosis and Calcific Aortic Valve Stenosis. Circulation. 2023. PMID: 37427430. doi:10.1161/CIRCULATIONAHA.122.063402
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。